Avicenna Laser Technology, Inc. and the company's HP-7.5 therapeutic laser device has become the healthcare industry's benchmark for laser therapy treatment for musculoskeletel and neuropathic pain management. 

We are a privately owned company, and the innovator of the first FDA cleared Class IV high power therapeutic laser modality. Our management team includes leading pioneers and clinicians working within the field of laser therapy.  It is our goal to be recognized by the healthcare industry as the leader in laser therapy research & development, clinical training, manufacturing, distribution and sales of high power therapuetic laser devices.

Avicenna Laser Technology's initial financial objective is to allocate investment capital toward business development growth initiatives including hiring first tier business development and management personnel who will assist in driving long-term shareholder value. 

To request an Investor Relations Frequently Asked Questions Document and Business Plan, please contact Dr. Bruce Coren at 561.722.1153 or write to: bcoren@avicennalaser.com.